Ambroxol Hydrochloride Granules

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity; it can also promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.

Ambroxol Hydrochloride

This product is a mucolytic agent and can be used for the expectorant treatment of acute bronchitis or lung diseases accompanied by sticky sputum.

It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum discharge function.

Adults and children over 12 years old: Usually in the first 2-3 days of treatment, take 30 mg orally 3 times a day (equivalent to 90 mg of ambroxol hydrochloride per day), then take 30 mg orally 2 times a day (equivalent to 60 mg of ambroxol hydrochloride per day). Take after meals

In a few cases, the following adverse reactions may occur: gastrointestinal discomfort (such as nausea and stomach pain), allergic reactions of the skin and mucous membranes (such as swelling, rash, erythema, itching), dyspnea, facial swelling, fever with chills. Rarely, patients feel dryness of the mouth and airways, increased saliva secretion, increased nasal secretions, constipation and difficulty urinating after taking this product. In some occasional cases, strong hypersensitivity reactions have occurred, accompanied by severe circulatory disorders (anaphylactic shock). In this case, emergency medical assistance is necessary. There has been a report of allergic skin inflammation (contact dermatitis). If adverse reactions not mentioned above are found during medication or the user does not understand the effects of the drug, please consult your doctor or pharmacist. Once an allergic reaction occurs, this product should not be taken again.

Patients who are allergic to the active ingredient of the granules: ambroxol hydrochloride or any other components are prohibited from taking this product. Patients with the following conditions must use this product under specific conditions and special supervision, and consult a doctor. Even if the above measures have been taken before, they should continue to do so. Patients with renal insufficiency or severe liver disease should be particularly cautious when taking this product (such as lengthening the interval between two doses or taking small doses). Patients with certain rare bronchial diseases accompanied by excessive secretions (such as asthenic ciliary syndrome) should be careful when taking this product orally, and must take it under the guidance of a physician, because it may cause secretions to block the bronchus. Patients with hereditary fructose intolerance must see a specialist before taking this product (see Precautions).

Precautions for children: 1. Children under 2 years old: Orally take 7.5 mg (half a pack) twice a day. 2. Children aged 2-5 years: Orally take 7.5 mg (half a pack) 3 times a day. 3. Children aged 6-12 years: Orally take 15 mg (one pack) 2-3 times a day. Precautions for pregnancy and lactation: Preclinical trials and a large amount of clinical experience after 28 weeks of pregnancy show that there is no adverse effect on pregnancy. However, during pregnancy, especially in the first three months of pregnancy, the drug should be used with caution. The drug can enter the breast milk, but the therapeutic dose should have no effect on the baby. Precautions for the elderly: This product is mainly excreted by the kidneys. Because elderly patients often have low renal function, the dosage should be reduced or the administration time should be extended.

If used in combination with antitussives (cough suppressants), there is a risk of blockage of secretions due to a weakened cough reflex, so the therapeutic range of the drug must be carefully considered before combined use. If used in combination with antibiotics (amoxicillin, cefuroxime, erythromycin or doxycycline), the penetration of antibiotics into the lung tissue may be increased.

Keep tightly closed in a cool, dry place.

30mg

24 months

Shanghai Huayuan Anhui Renji Pharmaceutical Co., Ltd.

• Founded in:

  2000-03-17

• Address:

  Area A, Taihe County Industrial Park, Anhui Province

• Tax NO.:

  91341222152061697K

• Registered Funds:

  38.105 million yuan

• Website:

  Log in to view

• Email:

  Log in to view